Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: An experimental study that supports a potential new application of BNCT

Applied Radiation and Isotopes

Volumn 67, Issue 7-8 SUPPL., 2009, Pages

  Monti Hughes, A ^a   Heber, E M ^a   Pozzi, E ^a   Nigg, D W ^b   Calzetta, O ^c   Blaumann, H ^c   Longhino, J ^c   Nievas, S I ^a   Aromando, R F ^d   Itoiz, M E ^a,d   Trivillin, V A ^a   Schwint, A E ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b IDAHO NATIONAL LABORATORY   (United States)

^c CENTRO ATÓMICO BARILOCHE   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

BNCT; Hamster cheek pouch; Locoregional recurrences; Oral cancer; Precancerous tissue

Indexed keywords

BNCT; HAMSTER CHEEK POUCH; LOCOREGIONAL RECURRENCES; ORAL CANCER; PRECANCEROUS TISSUE;

BORON; BORON COMPOUNDS; DIGESTIVE SYSTEM; MEATS; ONCOLOGY; SODIUM;

TUMORS;

4 BORONOPHENYLALANINE; BORON DERIVATIVE; GB 10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CHEEK POUCH; CONTROLLED STUDY; EXPERIMENTAL STUDY; FOLLOW UP; HAMSTER; IN VIVO STUDY; METASTASIS; MOUTH CANCER; NEUTRON CAPTURE THERAPY; NONHUMAN; PRECANCER; PRIORITY JOURNAL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BOROHYDRIDES; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CRICETINAE; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PHENYLALANINE; PRECANCEROUS CONDITIONS; RADIATION-SENSITIZING AGENTS; SULFHYDRYL COMPOUNDS; TISSUE DISTRIBUTION;

EID: 67649411593     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2009.03.070     Document Type: Article

References (10)

1. Braakhuis B.J.M., Tabor M.P., Kummer J.A., Leemans C.R., and Brakenhoff R.H. A genetic explanation of slaughter's concept of field cancerization. Cancer Res. 63 (2003) 1727-1730
2. Heber E., Trivillin V., Nigg D., Kreimann E.L., Itoiz M.E., Rebagliati R.J., Batistoni D., and Schwint A.E. Biodistribution of GB-10 (Na(2)(10)B10H10) in an experimental model of oral cancer in the hamster cheek pouch. Arch. Oral Biol. 49 (2004) 313-324
3. Heber E.M., Aromando R.F., Trivillin V.A., Itoiz M.E., Nigg D.W., Kreimann E.L., and Schwint A.E. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model. Arch. Oral Biol. 52 (2007) 273-279
4. Kreimann E.L., Itoiz M.E., Dagrosa A., Garavaglia R., Farías S., Batistoni D., and Schwint A.E. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Cancer Res. 61 (2001) 8775-8781
5. Kreimann E.L., Itoiz M.E., Longhino J., Blaumann H., Calzetta O., and Schwint A.E. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. Cancer Res. (Advances in Brief) 61 (2001) 8638-8642
6. Laconi E., Doratiotto S., and Vineis P. The microenvironments of multistage carcinogenesis. Semin. Cancer Biol. 18 5 (2008) 322-329
7. Schwint A.E., Savino T.M., Lanfranchi H.E., Marschoff E., Cabrini R.L., and Itoiz M.E. Nucleolar organizer regions in lining epithelium adjacent to squamous cell carcinoma of human oral mucosa. Cancer 73 (1994) 2674-2679
8. Smith B.D., and Haffty B.G. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat. Oncol. Investig. 7 3 (1999) 125-144
9. Trivillin V.A., Heber E.M., Itoiz M.E., Nigg D., Calzetta O., Blaumann H., Longhino J., and Schwint A.E. Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer. Appl. Radiat. Isot. 61 (2004) 939-945
10. Trivillin V.A., Heber E.M., Nigg D.W., Itoiz M.E., Calzetta O., Blaumann H., Longhino J., and Schwint A.E. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Radiat. Res. 166 (2006) 387-396